![1]()
News
SGLT2 inhibitor use tied to fewer atrial arrhythmias
December 2, 2021
A prospective study of nearly 14,000 patients who received an implantable cardiac device suggests that SGLT2-inhibitor treatment cuts atrial arrhythmias.
News
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
November 19, 2021
Study shows empagliflozin led to a consistent, significant relative risk reduction compared with placebo in the primary endpoint.
![1]()
News
Empagliflozin a winner in challenging arena of stabilized acute HF
November 19, 2021
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.
![1]()
News
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
November 17, 2021
A landmark trial proved empagliflozin’s efficacy in HFpEF, but many patients had “moderately reduced” EFs. The findings hold up even without them.
![1]()
News
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
November 17, 2021
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.
![1]()
News
EHRs have no impact on inpatient heart failure clinical choices or outcomes
November 15, 2021
Relative to usual care, prognostic information at the bedside provided no advantage for heart failure care.
![1]()
News
BP Track: Blood pressure control rates dropped during pandemic
November 14, 2021
Data culled from 24 health systems showed lower rates of blood pressure control during the COVID-19 pandemic.
News
Droperidol/midazolam combo curbs agitation in ED patients
November 2, 2021
A combination of haloperidol and lorazepam has been widely used to curb agitation in these patients, but droperidol and midazolam could be more effective, owing to faster onset of action.
News
Earlier discharge after surgery may come at the expense of post-discharge complications
October 29, 2021
“Our ultimate takeaway message is that there is a black hole that needs to be addressed between the time a patient gets discharged from the hospital to their first post-operative visit.”
News
A pill for C. difficile works by increasing microbiome diversity
October 25, 2021
“I think this marks a moment in this space where we’re going to have better, safer, and more available options for patients.”
